Target Price | CHF30.78 |
Price | CHF26.87 |
Potential | 14.54% |
Number of Estimates | 20 |
20 Analysts have issued a price target UBS Group 2026 . The average UBS Group target price is CHF30.78. This is 14.54% higher than the current stock price. The highest price target is CHF37.09 38.05% , the lowest is CHF20.50 23.71% . | |
A rating was issued by 23 analysts: 10 Analysts recommend UBS Group to buy, 6 to hold and 7 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the UBS Group stock has an average upside potential 2026 of 14.54% . Most analysts recommend the UBS Group stock at Purchase. |
15 Analysts have issued a sales forecast UBS Group 2025 . The average UBS Group sales estimate is CHF41.0b . This is 46.48% lower than the revenue of the last 12 months(TTM). The highest sales forecast is CHF43.3b 43.36% , the lowest is CHF38.9b 49.21% .
This results in the following potential growth metrics:
2024 | CHF76.5b | 18.99% |
---|---|---|
2025 | CHF41.0b | 46.46% |
2026 | CHF42.3b | 3.17% |
2027 | CHF44.0b | 4.07% |
2028 | CHF47.7b | 8.36% |
13 UBS Group Analysts have issued a net profit forecast 2025. The average UBS Group net profit estimate is CHF5.1b . This is 15.55% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF6.1b 36.17% , the lowest is CHF4.2b 4.63% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF4.4b | 82.05% |
---|---|---|
2025 | CHF5.1b | 15.55% |
2026 | CHF8.5b | 64.60% |
2027 | CHF11.4b | 34.31% |
2028 | CHF12.0b | 5.98% |
2024 | 5.81% | 84.92% |
---|---|---|
2025 | 12.54% | 115.86% |
2026 | 20.00% | 59.49% |
2027 | 25.81% | 29.05% |
2028 | 25.25% | 2.17% |
13 Analysts have issued a UBS Group forecast for earnings per share. The average UBS Group EPS is CHF1.62 . This is 15.71% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF1.91 36.43% , the lowest is CHF1.34 4.29% .
This results in the following potential growth metrics and future valuations:
2024 | CHF1.40 | 82.05% |
---|---|---|
2025 | CHF1.62 | 15.71% |
2026 | CHF2.66 | 64.20% |
2027 | CHF3.58 | 34.59% |
2028 | CHF3.79 | 5.87% |
Current | 19.98 | 544.52% |
---|---|---|
2025 | 17.27 | 13.56% |
2026 | 10.49 | 39.26% |
2027 | 7.81 | 25.55% |
2028 | 7.37 | 5.63% |
Based on analysts' sales estimates for 2025, the UBS Group stock is valued at an EV/Sales of 5.55 and an P/S ratio of 2.17 .
This results in the following potential growth metrics and future valuations:
Current | 2.97 | 14.41% |
---|---|---|
2025 | 5.55 | 86.98% |
2026 | 5.38 | 3.07% |
2027 | 5.17 | 3.91% |
2028 | 4.77 | 7.71% |
Current | 1.16 | 18.02% |
---|---|---|
2025 | 2.17 | 86.83% |
2026 | 2.10 | 3.07% |
2027 | 2.02 | 3.91% |
2028 | 1.86 | 7.71% |
Analyst | Rating | Action | Date |
---|---|---|---|
DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Dec 08 2024 |
HSBC |
Buy
➜
Buy
|
Unchanged | Nov 24 2024 |
LANDESBANK BADEN-WUERTTEMBERG |
Hold
➜
Hold
|
Unchanged | Nov 10 2024 |
BANCO SANTANDER |
Neutral
➜
Neutral
|
Unchanged | Nov 07 2024 |
BNP PARIBAS EXANE |
Neutral
➜
Neutral
|
Unchanged | Nov 07 2024 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Oct 01 2024 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Sep 08 2024 |
Analyst Rating | Date |
---|---|
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Dec 08 2024 |
Unchanged
HSBC:
Buy
➜
Buy
|
Nov 24 2024 |
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Hold
➜
Hold
|
Nov 10 2024 |
Unchanged
BANCO SANTANDER:
Neutral
➜
Neutral
|
Nov 07 2024 |
Unchanged
BNP PARIBAS EXANE:
Neutral
➜
Neutral
|
Nov 07 2024 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Oct 01 2024 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Sep 08 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.